APGE

Conviction 89HealthcareScan · Mon, Aug 10, 2026

APGE$134.66-0.14%

ResistanceSupportVol 14Insider sell

Vol MA14 1.29M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Apogee Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.apogeetherapeutics.com ↗

Price134.66

Change-0.14%

Gap-0.17%

Rel volume1.47×

Avg volume1.23M

Avg $ vol165.34M

SMA 20134.24

SMA 50119.23

SMA 20085.32

Price vs 50+12.94%

Price vs 200+57.83%

MA stackbullish

50/200 cross—

Supertrendup · 133.04

RSI (14)78

MACD hist-1.20

MACD cross—

Stoch %K / %D74 / 84

ADX (14)64

+DI / −DI48 / 9

RSI divergence—

MACD divergence—

ATR %+0.65%

ADR %0.20%

52w high134.84

52w low34.65

From 52w high-0.14%

Above 52w low+288.61%

New 52w highYes

SqueezeOn · 3d

Bollinger width0.61%

%B1.00

Donchian pos78.97%

Donchian high134.88

Donchian low133.81

AVWAP (52w high)134.67

vs AVWAP high-0.01%

AVWAP (52w low)96.57

vs AVWAP low+39.44%

OBV trendUp

Chaikin MF (20)0.07

Today vs 20d1.47×

Avg vol (14d)1.29M

Avg vol (20d)1.23M

Avg $ vol (20d)165.34M

Market cap—

RS 3m (vs SPY)+59.12%

RS 6m (vs SPY)+102.91%

RS line new highNo

Trend template8/8

Technical rank85.4

1 week+0.41%

1 month+0.75%

3 months+62.18%

6 months+116.35%

1 year+274.04%

YTD+77.69%

P/E-39.46

P/B—

P/S—

P/FCF-43.41

EPS-4.22

Div yield—

ROE—

ROA-19.78%

Debt/Eq—

Current32.59

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-40.46%

Price target127.03

Target upside-5.79%

Analyst ratingHold

Institutional133.72%

Ent. value9.64B

Revenue—

Net income-74.11M

Gross profit—

Free cash flow-232.6M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out61.9M

Employees261

ListedFri, Jul 14, 2023

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction89 / 100

Pattern quality—

Tech rank85.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance134.40

Support108.28

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in APGE

All disclosures →

No recent disclosed trades by Congress in APGE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in APGE · 1 buy · 9 sells

Insider	Side	Shares	Value	Traded	Filed
Dambkowski Carl Chief Medical Officer · Stock Option (Right to Buy) · 2026-08-05	Exercise	4.13K	—	2026-08-05	2026-08-07
Dambkowski Carl Chief Medical Officer · Common Stock · 2026-08-05	Sell	5.5K	$738K	2026-08-05	2026-08-07
Dambkowski Carl Chief Medical Officer · Common Stock · 2026-08-05	Exercise	4.13K	$94K	2026-08-05	2026-08-07
Dambkowski Carl Chief Medical Officer · Common Stock · 2026-07-14	Gift	8K	—	2026-07-14	2026-07-16
HENDERSON MICHAEL THOMAS Chief Executive Officer · Common Stock · 2026-07-10	Gift	75.05K	—	2026-07-10	2026-07-10
HENDERSON MICHAEL THOMAS Chief Executive Officer · Common Stock · 2026-07-08	Sell	20K	$2.7M	2026-07-08	2026-07-10
Dambkowski Carl Chief Medical Officer · Common Stock · 2026-06-22	Sell	26.4K	$3.5M	2026-06-22	2026-06-24
HENDERSON MICHAEL THOMAS Chief Executive Officer · Common Stock · 2026-06-22	Sell	80K	$11M	2026-06-22	2026-06-24
HENDERSON MICHAEL THOMAS Chief Executive Officer · Common Stock · 2026-06-10	Sell	6.77K	$557K	2026-06-10	2026-06-12
HENDERSON MICHAEL THOMAS Chief Executive Officer · Common Stock · 2026-06-10	Sell	7.65K	$634K	2026-06-10	2026-06-12

SEC filings

EDGAR filings in APGE · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.